4894.T
Cuorips Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 5,300.00
−2.39%Year over year
Reported trailing growth
- Revenue
- +947.1%
- EBITDA
- —
- EBIT
- -15.3%
- EPS
- +0.4%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -40.4%
- EBITDA
- —
- EPS
- -27.9%
Three-year CAGR
- Revenue
- +660.9%
- EBITDA
- +0.9%
- EBIT
- -0.3%
- Net income
- -1.9%
- EPS
- +6.2%
- Free cash flow
- -87.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026